ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of gene expression, today announced an oral presentation at the...

From November 11 to 22, 2024, the 29th Conference of the Parties to the United Nations Framework Convention on Climate Change (COP29) is set to commence in Baku, the capital of Azerbaijan. Tuya...

Shanghai Electric signed new memoranda of cooperation and strategic agreements with Carrier Group and Svenska Kullagerfabriken AB (SKF) China Sales Co., Ltd. at CIIE 2024 SHANGHAI, Nov. 11, 2024...

STARt-001 is the first clinical study to evaluate Marengo's novel, selective Vβ TCR agonist technology to promote in vivo expansion and reprogramming of tumor-infiltrating lymphocytes (TILs) in...

-ST101 Phase 2 data demonstrates activation of the tumor immune microenvironment in glioblastoma (GBM)- -ST316 Phase 1 data demonstrates antagonism of β-catenin-driven immune exclusion-...